atb200
Recombinant proteinexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02675465)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- atb200
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04138277 | Phase 3 | Dec 31, 2019 | Amicus Therapeutics |
| NCT03911505 | Phase 3 | Jul 31, 2019 | Amicus Therapeutics |
| NCT03729362 | Phase 3 | Dec 4, 2018 | Amicus Therapeutics |
| NCT02675465 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2016 | Amicus Therapeutics |
| NCT03865836 | N/A | — | Amicus Therapeutics |
| NCT04327973 | N/A | — | Amicus Therapeutics |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amicus Therapeutics | For profit | 6 | 6 | 3 | 2016 |
1 organizations
Page 1 / 1